Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA049963-05
Application #
3194334
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-06-23
Project End
1993-07-31
Budget Start
1993-04-01
Budget End
1993-07-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Huang, R P; Fan, Y; de Belle, I et al. (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72:102-9
Huang, R P; Fan, Y; Ni, Z et al. (1997) Reciprocal modulation between Sp1 and Egr-1. J Cell Biochem 66:489-99
Gjerset, R A; Fakhrai, H; Shawler, D L et al. (1995) Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway. In Vitro Cell Dev Biol Anim 31:207-14
Huang, R P; Liu, C; Fan, Y et al. (1995) Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 55:5054-62
Huang, R P; Darland, T; Okamura, D et al. (1994) Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 9:1367-77
Mercola, D; Carpenter, P M; Grover-Bardwick, A et al. (1992) Rapid, complete and reversible transformation by v-sis precedes irreversible transformation. Oncogene 7:1793-803
Carpenter, P M; Mercola, M; Mercola, D (1991) Reversible transformation by v-sis: a model cell line for analysis of transformation by antisense methods. Antisense Res Dev 1:289-95
Ragona, G; Edwards, S A; Mercola, D A et al. (1991) The transcriptional factor Egr-1 is synthesized by baculovirus-infected insect cells in an active, DNA-binding form. DNA Cell Biol 10:61-6
Wu, J X; Carpenter, P M; Gresens, C et al. (1990) The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 5:989-1000